The benzylisoquinoline alkaloids, berberine and coptisine, act against camptothecin-resistant topoisomerase I mutants. 2021

Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan.

DNA replication inhibitors are utilized extensively in studies of molecular biology and as chemotherapy agents in clinical settings. The inhibition of DNA replication often triggers double-stranded DNA breaks (DSBs) at stalled DNA replication sites, resulting in cytotoxicity. In East Asia, some traditional medicines are administered as anticancer drugs, although the mechanisms underlying their pharmacological effects are not entirely understood. In this study, we screened Japanese herbal medicines and identified two benzylisoquinoline alkaloids (BIAs), berberine and coptisine. These alkaloids mildly induced DSBs, and this effect was dependent on the function of topoisomerase I (Topo I) and MUS81-EME1 structure-specific endonuclease. Biochemical analysis revealed that the action of BIAs involves inhibiting the catalytic activity of Topo I rather than inducing the accumulation of the Topo I-DNA complex, which is different from the action of camptothecin (CPT). Furthermore, the results showed that BIAs can act as inhibitors of Topo I, even against CPT-resistant mutants, and that the action of these BIAs was independent of CPT. These results suggest that using a combination of BIAs and CPT might increase their efficiency in eliminating cancer cells.

UI MeSH Term Description Entries
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D001599 Berberine An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal. Umbellatine
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D053903 DNA Breaks, Double-Stranded Interruptions in the sugar-phosphate backbone of DNA, across both strands adjacently. Double-Stranded DNA Breaks,Double-Strand DNA Breaks,Double-Stranded DNA Break,Break, Double-Strand DNA,Break, Double-Stranded DNA,Breaks, Double-Strand DNA,Breaks, Double-Stranded DNA,DNA Break, Double-Strand,DNA Break, Double-Stranded,DNA Breaks, Double Stranded,DNA Breaks, Double-Strand,Double Strand DNA Breaks,Double Stranded DNA Break,Double Stranded DNA Breaks,Double-Strand DNA Break
D059004 Topoisomerase I Inhibitors Compounds that inhibit the activity of DNA TOPOISOMERASE I. DNA Topoisomerase I Inhibitor,DNA Topoisomerase III Inhibitor,DNA Topoisomerase III Inhibitors,DNA Type 1 Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitors,Topoisomerase 1 Inhibitor,Topoisomerase 1 Inhibitors,Topoisomerase 3 Inhibitor,Topoisomerase 3 Inhibitors,Topoisomerase I Inhibitor,Topoisomerase III Inhibitor,Topoisomerase III Inhibitors,DNA Topoisomerase I Inhibitors,DNA Type 1 Topoisomerase Inhibitors,1 Inhibitor, Topoisomerase,3 Inhibitor, Topoisomerase,3 Inhibitors, Topoisomerase,I Inhibitor, Topoisomerase,III Inhibitor, Topoisomerase,III Inhibitors, Topoisomerase,Inhibitor, Topoisomerase 1,Inhibitor, Topoisomerase 3,Inhibitor, Topoisomerase I,Inhibitor, Topoisomerase III,Inhibitors, Topoisomerase 1,Inhibitors, Topoisomerase 3,Inhibitors, Topoisomerase I,Inhibitors, Topoisomerase III
D019008 Drug Resistance, Neoplasm Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures. Antibiotic Resistance, Neoplasm,Antineoplastic Drug Resistance,Drug Resistance, Antineoplastic,Antineoplastic Agent Resistance,Neoplasm Drug Resistance,Resistance, Antineoplastic Agent,Resistance, Antineoplastic Drug

Related Publications

Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
November 1988, Cancer research,
Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
January 2006, Nucleic acids research,
Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
October 1993, The Journal of biological chemistry,
Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
March 1988, The Journal of biological chemistry,
Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
July 2018, Organic letters,
Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
February 2023, Communications chemistry,
Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
October 2011, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
July 2002, Cancer research,
Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
March 1995, The Journal of biological chemistry,
Naomi Inoue, and Takeshi Terabayashi, and Yuri Takiguchi-Kawashima, and Daisuke Fujinami, and Shigeru Matsuoka, and Masanori Kawano, and Kazuhiro Tanaka, and Hiroshi Tsumura, and Toshimasa Ishizaki, and Hisashi Narahara, and Daisuke Kohda, and Yoshihiro Nishida, and Katsuhiro Hanada
July 1999, Biochemistry,
Copied contents to your clipboard!